Manhattan Scientifics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 -100.0% -€1.01M -57.3% N/A -€163.98K -45.6% N/A
    €43.15K +0.0% -€2.36M -25.0% -5,460.0% +18 pp -€301.20K -17.1% -698.0% +1.4 pp
    €43.15K +0.0% -€3.14M -184.4% -7,278.0% -160 pp -€363.34K +9.6% -842.0% -0.74 pp
    €43.15K -48.5% €3.72M -453.0% 8,628.0% +99 pp -€331.41K +21.5% -768.0% -4.4 pp
    €83.71K +∞% -€1.05M -85.3% -1,259.8% -13 pp -€272.72K -53.7% -325.8% -3.3 pp
    €0.00 -100.0% -€7.19M -639.1% N/A -€588.59K -12.9% N/A
    €122.55K -5.3% €1.33M -125.3% 1,088.7% +52 pp -€675.76K -82.8% -551.4% +25 pp
    €129.46K +134.4% -€5.27M -176.2% -4,072.0% -170 pp -€3.92M -223.8% -3,030.0% -88 pp
    €55.23K -90.0% €6.91M -310.6% 12,518.8% +130 pp €3.17M -246.9% 5,734.4% +61 pp
    €554.07K -1.5% -€3.28M +97.4% -592.7% -3.0 pp -€2.16M +218.3% -389.3% -2.7 pp
    €562.70K -5.9% -€1.66M -7.8% -295.7% +0.059 pp -€677.48K -27.2% -120.4% +0.35 pp
    €598.08K +0.9% -€1.80M -8.6% -301.6% +0.31 pp -€930.35K -9.7% -155.6% +0.18 pp
    €592.91K -59.3% -€1.97M +5,218.6% -332.9% -3.3 pp -€1.03M -358.4% -173.8% -2.0 pp
    €1.46M +166.4% -€37.11K -90.4% -2.6% +0.68 pp €398.72K -213.8% 27.4% +0.92 pp
    €546.30K -26.1% -€384.91K -79.2% -70.5% +1.8 pp -€350.39K -42.0% -64.1% +0.18 pp
    €738.76K +∞% -€1.85M -28.9% -250.2% -2.5 pp -€604.13K +30.4% -81.8% -0.82 pp
    €0.00 +NaN% -€2.60M +77.9% N/A -€463.45K +62.2% N/A
    €0.00 +NaN% -€1.46M +673.5% N/A -€285.66K -55.9% N/A
    €0.00 -100.0% -€189.00K -85.6% N/A -€648.14K +72.2% N/A
    €129.46K -50.0% -€1.31M -40.9% -1,011.3% -1.6 pp -€376.28K +73.7% -290.7% -2.1 pp
    €258.91K +92.3% -€2.22M -36.2% -856.3% +17 pp -€216.62K -73.1% -83.7% +5.2 pp
    €134.63K +∞% -€3.48M -39.5% -2,582.1% -26 pp -€806.08K -60.6% -598.7% -6.0 pp
    €0.00 -100.0% -€5.75M +40.7% N/A -€2.05M -39.7% N/A
    €215.76K +24,900.0% -€4.09M -51.7% -1,894.4% +9.8K pp -€3.39M +163.5% -1,571.6% +1.5K pp
    €863.04 -€8.46M -980,000.0% -€1.29M -149,100.0%

    Notifications